Uveal Melanoma Guideline

The Uveal Melanoma Guideline is currently being updated under the chairmanship of Dr Paul Nathan.

 

 

 

Background

There is a need for a specialist guideline on uveal (ocular) melanoma as this form of the disease is a very rare condition which is managed differently from other melanomas. Comprehensive guidance on this subject was developed for the first time in 2015. While much of the guideline is still current, the following sections are being updated or added:

• molecular pathology and features
• prognostic markers
• loco-regional management of hepatic predominant disease
• management of metastatic disease
• adjuvant radiation therapy
• support of patients

Members of the Uveal Melanoma Guideline Development Group:

• Dr Paul Nathan Chairman Medical Oncologist
• Prof Sarah Coupland Pathologist
• Dr Rachel Lewis Clinical Oncologist
• Dr Sachin Modi Interventional Radiologist
• Dr Sukaina Rashid Medical Oncologist
• Dr Joe   Sacco Medical oncologist
• Dr Karen  Sisley Senior Lecturer
• Dr Samra  Turajlic Medical Oncologist
• Dr Matthew  Wheater Medical Oncologist
• Ms Audrey  Woraker Patient Representative
• Ms Nancy Turnbull, Project Manager

 

Note: The Uveal Melanoma Guideline is currently being updated under the chairmanship of Dr Paul Nathan. Any queries about this process should be directed to info@melanomafocus.com.

The original guideline has been published in The European Journal of Cancer (EJC) (Eur J Cancer 2015 Nov;51(16):2404-12) with open access. Follow this link for the PubMed abstract.

Click here for the original guideline

• Press Release: Melanoma Focus—-

• News Article by NICE: ‘NICE grants seal of approval to guidelines on rare form of cancer’

• Uveal Melanoma National Guideline Report Summary

• Lay Summary of information for patients, carers and public

• Resources Page: Full Report & supporting documents

 

 

printer-friendly version